1. Enhanced cross‐priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide. Issue 3 (13th June 2013) Authors: Henry, Jake Y.; Labarthe, Marie‐Christine; Meyer, Brendan; Dasgupta, Prokar; Dalgleish, Angus G.; Galustian, Christine Journal: Immunology Issue: Volume 139:Issue 3(2013:Jul.) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal Immunity. Issue 5 (1st June 2016) Authors: Shaw, Tanya J.; Zhang, Xiang Y.; Huo, Zhiming; Robertson, David; Lovell, Patricia A.; Dalgleish, Angus G.; Barton, Desmond P.J. Journal: International journal of gynecological cancer Issue: Volume 26:Issue 5(2016) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal Immunity. Issue 5 (June 2016) Authors: Shaw, Tanya J.; Zhang, Xiang Y.; Huo, Zhiming; Robertson, David; Lovell, Patricia A.; Dalgleish, Angus G.; Barton, Desmond P.J. Journal: International journal of gynecological cancer Issue: Volume 26:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma. (2020) Authors: Dalgleish, Angus G.; McLean, Emma; Patel, Nirav; Rahman, Najib Journal: Respiratory medicine case reports Issue: Volume 29(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2+γδ T cells in the modulation of immune response to tumour?. Issue 3 (16th September 2020) Authors: Sparrow, Emma L.; Fowler, Daniel W.; Fenn, Joe; Caron, Jonathan; Copier, John; Dalgleish, Angus G.; Bodman‐Smith, Mark D. Journal: Immunology Issue: Volume 161:Issue 3(2020) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The failure of radical treatments to cure cancer: can less deliver more?. Issue 5 (October 2018) Authors: Dalgleish, Angus G.; Stern, Peter L. Journal: Therapeutic advances in vaccines and immunotherapy Issue: Volume 6:Issue 5/6(2018) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The successful treatment of metastatic androgen receptor–positive tumours of parotid origin with androgen receptor blockade and immunotherapy. (May 2019) Authors: Dalgleish, Angus G.; Di Palma, Silvana; Nathan, Kannon; Powell, Barry; Patel, Nirav; Fusi, Alberto Journal: European journal of cancer Issue: Volume 113(2019) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Zoledronic acid causes γδ T cells to target monocytes and down‐modulate inflammatory homing. Issue 4 (December 2014) Authors: Fowler, Daniel W.; Copier, John; Dalgleish, Angus G.; Bodman‐Smith, Mark D. Journal: Immunology Issue: Volume 143:Issue 4(2014:Dec.) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗